A vagina treatment device comprises a vaginal dilator (100) and a drug spraying mechanism (200). The vaginal dilator (100) comprises a first dilation sheet (110) and a second dilation sheet (120) that are disposed opposite to each other vertically. The first dilation sheet (110) and the second dilation sheet (120) are hingedly connected with each other and cooperate with each other to form an operation channel (150). The drug spraying mechanism (200) comprises at least one drug spraying tube (210) one end of which enters the operation channel (150) and comprises an ejection power device (230) communicating with the drug spraying tube (210). By extending the vaginal dilator (100) into a vagina, the vaginal dilator (100) is slowly expanded, and at this time, the drug spraying tube (210) located in the operation channel (150) can spray a drug to a lesion at an uterine neck or a vaginal wall by means of the ejection power device (230), thereby achieving the effect of disease treatment. Spraying allows the drug to distributed more uniform and makes the treatment effect better in addition, the spraying allows the drug to be directly spayed to the lesion, a patient does not feel painful and uncomfortable. Operations are simple, time and labor are saved, and a person can treat her diseases by herself, thereby helping to improve the health level of the majority of women.Un dispositif de traitement vaginal comprend un dilatateur vaginal (100) et un mécanisme de pulvérisation de médicament (200). Le dilatateur vaginal (100) comprend une première feuille de dilatation (110) et une seconde feuille de dilatation (120) verticalement opposées lune à lautre. La première feuille de dilatation (110) et la seconde feuille de dilatation (120) sont reliées de manière articulée lune à lautre et coopèrent lune avec lautre pour former un canal dexploitation (150). Le mécanisme de pulvérisation de médicament (200) comprend au moins un tube pulvérisation de médicament (210) dont une extrémité
